Nordson CORP 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NASDAQ
Nordson Corporation announced the establishment of a new commercial paper program allowing for up to $1.2 billion in unsecured notes to fund general corporate purposes.
NASDAQ
Nordson Corporation announced record-breaking second quarter fiscal 2026 results, with sales reaching $741 million and adjusted earnings per diluted share hitting $2.86, prompting an increase in full-year financial guidance.
NASDAQ
Nordson Corporation shareholders approved the re-election of three directors, ratified Ernst & Young LLP as independent auditors, and endorsed executive compensation at their 2026 Annual Meeting.
NASDAQ
Nordson Corporation has entered into a new $1.2 billion senior unsecured multicurrency revolving credit facility, maturing in 2031, to enhance financial flexibility and refinance existing debt.
NASDAQ
Nordson Corporation announced record fiscal year 2025 sales and adjusted earnings per share, alongside a strong fourth quarter performance and optimistic guidance for fiscal year 2026.
NASDAQ
Nordson Corporation's Compensation Committee adopted a new Executive Severance Policy, effective November 1, 2025, providing protections for certain executive officers.
NASDAQ
Nordson Corporation reported robust third-quarter fiscal 2025 results, exceeding expectations with double-digit growth in sales, adjusted EPS, and EBITDA, while authorizing an additional $500 million in share repurchases.
NASDAQ
Nordson Corporation announced the appointment of Joseph M. Rutledge as its new Vice President and Chief Accounting Officer, effective July 14, 2025, following the departure of Stephen Shamrock.
NASDAQ
Nordson Corporation has filed an amendment to its 8-K report, providing details on the separation agreement and compensation package for Stephen Lovass, former segment leader for Medical and Fluid Solutions, who departed the company.
NASDAQ
Nordson Corporation announced its second quarter fiscal 2025 results, reporting a 5% year-over-year sales increase to $683 million and adjusted earnings per diluted share of $2.42, while providing third quarter sales guidance of $710 million to $750 million.
NASDAQ
Justin Hall has been promoted to Executive Vice President and Medical and Fluid Solutions segment leader, replacing Stephen Lovass who is leaving the company.
NASDAQ
Nordson Corporation held its 2025 Annual Meeting on March 4, 2025, where shareholders elected directors, ratified the appointment of Ernst & Young LLP, and approved executive compensation.
NASDAQ
Nordson Corporation's Q1 2025 sales decreased by 2.8% year-over-year, but backlog grew by 15%, and the company provides Q2 guidance.
NASDAQ
Nordson Corporation announced record sales for fiscal year 2024, driven by acquisitions, while also providing a conservative outlook for fiscal year 2025.
NASDAQ
Nordson Corporation has successfully completed a $600 million offering of 4.500% notes due in 2029 to refinance existing debt and for general corporate purposes.
NASDAQ
Nordson Corporation's third quarter results show a slight revenue increase and adjusted earnings per share above guidance, while updating full-year revenue guidance to include the Atrion acquisition.
NASDAQ
Nordson Corporation has successfully completed its acquisition of Atrion Corporation, a move that broadens its medical offerings into new markets and therapies.
NASDAQ
Nordson Corporation has entered into a $500 million term loan agreement and increased its existing revolving credit facility by $72.5 million to support its acquisition of Atrion Corporation.
NASDAQ
Nordson Corporation has agreed to acquire Atrion Corporation for $460 per share in cash, valuing the medical device company at approximately $800 million.
NASDAQ
Nordson Corporation has announced a definitive agreement to acquire Atrion Corporation for $460 per share in cash, valuing the company at approximately $800 million.
NASDAQ
Nordson Corporation reported second quarter fiscal 2024 results with sales comparable to the prior year, but adjusted earnings per share decreased, and the company updated its full-year guidance.
NASDAQ
Nordson Corporation has announced a temporary blackout period for its employee benefit plans and for directors and officers, due to a change in recordkeeping platforms.
NASDAQ
Nordson Corporation has appointed Daniel Hopgood as its new Executive Vice President and Chief Financial Officer, effective May 20, 2024.
NASDAQ
Nordson Corporation held its 2024 Annual Meeting, electing directors, ratifying the accounting firm, approving executive compensation, and appointing a new board chair.
NASDAQ
Nordson Corporation announced a 4% increase in sales for the first quarter of fiscal year 2024, driven by acquisitions and growth in certain segments, while also narrowing its full-year guidance.
NASDAQ
Nordson Corporation has appointed Annette Clayton, former CEO of Schneider Electric North America, to its board of directors, effective April 1, 2024.
NASDAQ
Nordson Corporation has appointed Christopher L. Mapes, former CEO of Lincoln Electric, to its board of directors, effective January 16, 2024.